Combination of photodynamic therapy (PDT) and melphalan in experimental tumors. 1994

J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
MRC Radiobiology Unit, Didcot, Oxon, UK.

OBJECTIVE To investigate whether application of "early" photodynamic therapy (PDT) using a disulphonated aluminium phthallocyanine photosensitizer can potentiate the action of melphalan in experimental RIF-1 tumors in vivo. METHODS Tumors were irradiated with laser light of wavelength 675 nm 60 min after treatment with the photosensitizer and 15 min after melphalan. Melphalan pharmacokinetics were measured using high performance liquid chromatography with optical detection. RESULTS Melphalan and PDT when given alone, caused a significant delay in tumor growth. This was increased for the combined treatment. Pharmacokinetic analyses showed that levels of free, unreacted melphalan in freely circulating blood are unaffected by combined treatment. However, significant differences in tumor levels were observed between treatment with melphalan alone or in combination. Whereas in the former, melphalan is still present in tumors after 2 h, it was not detectable even at the earliest time of 15-23 min for the combined treatment. CONCLUSIONS The antitumor effects were additive with no evidence of significant potentiation.

UI MeSH Term Description Entries
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
January 1984, Critical reviews in oncology/hematology,
J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
January 2015, Molecular pharmaceutics,
J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
January 2013, Clinical endoscopy,
J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
January 2018, Journal of pharmaceutical investigation,
J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
December 1994, International journal of oral and maxillofacial surgery,
J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
December 2016, Journal of biophotonics,
J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
September 2016, Nihon rinsho. Japanese journal of clinical medicine,
J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
February 1997, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
November 2020, Cancers,
J M Sansom, and B Sutton, and N Reeves, and J K Bradley, and P J Wood, and J C Bremner, and G E Adams, and I J Stratford
October 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Copied contents to your clipboard!